Serum Level and Genetic Polymorphism of Interleukin-33 in Iraqi Patients with Type 2 Diabetes Mellitus
Diyala Journal of Medicine · 25.04.2026 · 30 (1) · 83-100
DOI: 10.26505/djm.v30i1.1333 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diyala Journal of Medicine, online erschienen am 25.04.2026. Verfasst von Dunya Abdullah Mohammed und 4 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Diabetes mellitus
Abstract (Originalsprache)
Background
Type 2 diabetes mellitus (T2DM) is characterized by insulin deficiency and resistance. This study evaluated serum interleukin‑33 (IL‑33) and its soluble receptor (sST2), plus two IL‑33 gene polymorphisms (rs7044343, rs1929992), for association with T2DM in Iraqi patients. Patients and Methods: In this case–control study, 120 T2DM patients and 80 age and sex matched healthy controls were used. Fasting blood glucose and glycated hemoglobin (HbA1c) confirmed diabetic status. Serum IL 33 and sST2 concentrations were measured by ELISA. Genotyping of IL 33 rs7044343 and rs1929992 was performed via PCR–RFLP. Allele and genotype frequencies were compared using χ² tests; associations were expressed as odds ratios (ORs) with 95% confidence intervals (CIs). Statistical significance was set at p < 0.05.
Results
Compared to controls, T2DM patients showed significantly higher serum IL 33 (mean ± SD: 43.2 ± 12.7 vs 28.5 ± 9.3 pg/mL, p < 0.001) and sST2 (56.8 ± 14.1 vs 34.7 ± 10.5 ng/mL, p < 0.001). The IL 33 rs1929992 variant exhibited no significant difference between groups (p = 0.30). In contrast, the rs7044343 AA genotype was more frequent in T2DM patients than controls (AA = 34% vs 18%; OR = 2.35, 95% CI 1.22–4.52, p = 0.010), while the CC genotype conferred a protective effect (CC = 22% vs 38%; OR = 0.48, 95% CI 0.26–0.89, p = 0.018).
Conclusion
Elevated IL 33 and sST2 levels, together with the rs7044343 AA genotype, are associated with increased susceptibility to T2DM in Iraqi patients. These findings support IL 33 pathway involvement in T2DM pathogenesis. Keywords: IL-33, T2DM, Lipid profile, ST2 receptor.
Zitieren
APA
Mohammed, D. A., Mahmood, S. K., Hameed, M. A., Ibrahim, S. M., & Mahmoud, O. A. (2026). Serum Level and Genetic Polymorphism of Interleukin-33 in Iraqi Patients with Type 2 Diabetes Mellitus. Diyala Journal of Medicine, 30(1), 83-100. https://doi.org/10.26505/djm.v30i1.1333
Vancouver
Mohammed DA, Mahmood SK, Hameed MA, Ibrahim SM, Mahmoud OA. Serum Level and Genetic Polymorphism of Interleukin-33 in Iraqi Patients with Type 2 Diabetes Mellitus. Diyala Journal of Medicine. 2026;30(1):83-100. doi:10.26505/djm.v30i1.1333
BibTeX
@article{Mohammed2026,
author = {Mohammed, Dunya Abdullah and Mahmood, Samia Khalil and Hameed, Mohammed A. and Ibrahim, Sahar M. and Mahmoud, Omar A},
title = {Serum Level and Genetic Polymorphism of Interleukin-33 in Iraqi Patients with Type 2 Diabetes Mellitus},
journal = {Diyala Journal of Medicine},
year = {2026},
volume = {30},
number = {1},
pages = {83--100},
doi = {10.26505/djm.v30i1.1333}
}
EUVIMED